Point of Care

// CONGEN develops and produces more than 5 million PCR beads

// Customized assays according to customer requirements

More details

Research and development

// Over 25 years of experience in development and validation
// More than 300 development projects completed

Projects

Clinical Diagnostics

// Diagnostic detection kits developed in Germany
// unique-reproducible-sensitive

Products

Food Analysis

// Identification & quantification of relevant parameters
// fast-specific-safe

Products

Company

// founded in 1998
// in the heart of the Berlin Science Campus

Quality

Welcome to CONGEN

Since its founding in 1998, CONGEN Biotechnologie GmbH has been an innovative Berlin biotechnology company in the field of molecular DNA and RNA analysis. Our core competency is the development and application of real-time PCR methods for food- and water analyses, clinical and point-of-care diagnostics as well as personalised medicine in the context of companion diagnostics. Each detection method is developed by us in house and validated in respect of the requirements of standards, customers and/or the market.

Our products are marketed worldwide by us and our distribution partner R-Biopharm under the brand names SureFood®, SureFast®, RIDA®GENE and RIDA®UNITY, which can be used on all common real-time PCR devices.

Food Analysis

In the field of food analysis, CONGEN offers nucleic acid extractions and methods for the detection of allergenic substances, genetic modifications, microorganisms and the identification of animal and plant species.

CONGEN Biotechnologie - Klinische Diagnostik

Clinical Diagnostics

The products in the clinic line include detection methods for nosocomial and respiratory diagnostics, sexually transmitted diseases, stool and periodontitis diagnostics. The detection methods offered are produced in accordance with medical standards.

CONGEN Produkte - Personalisierte Medizin

Personalized medicine

Modern diagnostics enable doctors to identify the specific genetic, molecular and cellular characteristics of a patient and derive targeted therapies. CONGEN develops highly specific diagnostic rapid test systems for this purpose.

CONGEN Biotechnologie Forschung und Entwicklung

Research & Development

Design and validation of multiplex real-time PCR methods based on customer requirements or unsolved analytical problems.

News & Dates

Current developments, new products, events and information from the field of science can be found on our news page.

Company

Since 1998, CONGEN Biotechnologie GmbH has been located at the science location Berlin Buch in the north of Berlin.

“Small enough to be flexible and fast,

big enough to meet every customer requirement.”

Leading in the development of real-time PCR-based detection methods

Development of user-friendly solutions for your analytical problem

Specialist in the design, validation and commercialization of multi-complex applications

Highest quality standards according to international regulations

News – Congen Biotechnologie GmbH

New AOAC-RI Approval: SureFast® PCR Kits for Reliable STEC & E. coli Serotyping

Escherichia coli (E. coli) is a gram-negative, rod-shaped bacterium. It is amongst the most extensively studied bacteria worldwide and constitues a natural component of the gut flora of humans and warm-blooded mammals. STEC: a particularly pathogenic group of E. coli...

Superfood as a Global Trend: Opportunities and Challenges for Food Safety

Superfoods are more than just a temporary dietary trend. Products such as chia, açai, matcha, curcuma, avocados, and quinoa have gained global recognition as integral components of a modern diet. There is an increasing demand from consumers for healthy, functional,...

Cereulide in food: significance of detecting emetic Bacillus cereus

The current precautionary recalls of infant formula due to possible contamination with the toxin cereulide have once again drawn attention to emetic representatives of the Bacillus cereus group. The German Federal Institute for Risk Assessment (BfR)